Skip to Content

What type of Hepatitis C is Zepatier used to treat?

Answers (1)

Official Answer by Drugs.com 5 May 2016

Zepatier (generic name elbasvir and grazoprevir) from Merck and Co. is a once-daily oral agent for hepatitis C virus (HCV) and was FDA-approved in February 2016.

Zepatier is given with or without ribavirin for HCV in adults with genotypes 1 (the most common, 70% of HCV patients) or 4 (the least common, ~1% of HCV patients). Zepatier is used only if your HCV has these specific genetic markers, for which your doctor will test.

In clinical trials, cure rates at 12 weeks ranged from 94 to 97 percent in genotype 1 and from 97 to 100 percent in genotype 4-infected subjects. Common side effects with Zepatier include headache, nausea, and fatigue.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How is Lartruvo administered?

Posted 9 days ago 1 answerFAQ by Drugs.com

What is the difference between Flublok and Flublok Quadrivalent?

Posted 9 days ago 1 answerFAQ by Drugs.com

What is the difference between Amjevita and Humira?

Posted 9 days ago 1 answerFAQ by Drugs.com

What are the clinical benefits of Exondys 51?

Posted 9 days ago 1 answerFAQ by Drugs.com

How is Troxyca ER formulated to be abuse deterrent?

Posted 9 days ago 1 answerFAQ by Drugs.com